Results 261 to 270 of about 168,320 (317)
Some of the next articles are maybe not open access.
HPV and HPV-Associated Diseases
Infectious Disease Clinics of North America, 2013Human papillomavirus (HPV) is the most common sexually transmitted infection. HPV is associated with a significant burden of disease and cancer, including anogenital warts and recurrent respiratory papillomatosis, and anogenital and oropharyngeal cancers.
Eileen Dunne
exaly +3 more sources
Circulating HPV DNA in HPV-associated cancers
Clinica Chimica Acta, 2023Human papillomavirus (HPV) infections are the primary cause of almost all cervical cancers, anal cancers, and a variable proportion of other anogenital tumors, as well as head and neck cancers. Circulating HPV DNA (cHPV-DNA) is emerging as a biomarker with extensive potential in the management of HPV-driven malignancies.
Guigao Lin, Jinming Li
openaire +2 more sources
Immunobiology of HPV and HPV vaccines
Gynecologic Oncology, 2008Genital human papillomavirus (HPV) infection with both low- and high-risk types is common, but most infections resolve as a result of a cell-mediated immune response. Failure to induce an effective immune response is related to inefficient activation of innate immunity and ineffective priming of the adaptive immune response; this defective immune ...
openaire +2 more sources
Best Practice & Research Clinical Obstetrics & Gynaecology, 2006
The ability to generate human papillomavirus virus (HPV)-like particles by the synthesis and self-assembly in vitro of the major virus capsid protein L1 has transformed our prospects for preventing cervical carcinoma in women. These particles provide vaccines that are immunogenic and safe, and data from proof-of-principle efficacy trials strongly ...
openaire +2 more sources
The ability to generate human papillomavirus virus (HPV)-like particles by the synthesis and self-assembly in vitro of the major virus capsid protein L1 has transformed our prospects for preventing cervical carcinoma in women. These particles provide vaccines that are immunogenic and safe, and data from proof-of-principle efficacy trials strongly ...
openaire +2 more sources
Detection of HPV-20, HPV-23, and HPV-DL332 in a solitary eyelid syringoma
American Journal of Ophthalmology, 2000To report evidence of many human papillomavirus types occurring in a solitary syringoma clinically appearing as a papilloma.A 57-year-old man presented with a 10-year history of an upper eyelid tumor. Histopathology, human papillomavirus-nested polymerase chain reaction, human papillomavirus-DNA cloning into vector pCR2.1, sequencing, and computer ...
A, Assadoullina +3 more
openaire +2 more sources
Preclinical models of HPV+ and HPV− HNSCC in mice: An immune clearance of HPV+ HNSCC
Head & Neck, 2009AbstractBackground.To investigate whether human papilloma virus (HPV)‐specific immune mechanisms can result in tumor clearance, we have created HPV+ and HPV− tonsil cells that form squamous cancers in immune‐competent mice. Here, we determine that an immune‐specific response can clear HPV+ tumor cells and the cellular requirements to mediate this tumor
Robin, Williams +5 more
openaire +2 more sources
HER2 and HER3 in HPV+ and HPV− HNSCC—Letter
Clinical Cancer Research, 2016The nice experiments performed by Pollock and colleagues showed that Human papillomavirus (HPV) infection coincided with overexpression of HER2 (ERBB2), HER3 (ERBB3), and the associated HER2:HER3 heterodimer and that this may contribute to EGFR therapy resistance.
Jean-Pascal, Machiels +2 more
openaire +2 more sources
HER2 and HER3 in HPV+ and HPV− HNSCC—Response
Clinical Cancer Research, 2016We appreciate the perspective of Drs. Machiels, Galot and Schmitz of our article, which was published earlier this year in Clinical Cancer Research , prior to the publication of the LUX-Head and Neck 1 trial results.
openaire +2 more sources
Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine.
Reviews in obstetrics & gynecology, 2011Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, and persistent HPV infection is strongly associated with risk of cervical cancer and genital warts. The recently approved quadrivalent HPV vaccine targets the HPV strains responsible for approximately 70% of cervical cancers and 90% of genital warts.
Kari P, Braaten, Marc R, Laufer
openaire +1 more source